Recent Advances Across COVID-19 Management, Microbiomics, Genomics, Transcriptomics, and Proteomics Technologies

Recent Advances Across COVID-19 Management, Microbiomics, Genomics, Transcriptomics, and Proteomics Technologies

RELEASE DATE
19-Jun-2020
REGION
Global
Research Code: D759-00-15-00-00
SKU: HC03305-GL-TA_24510

$950.00

Special Price $712.50 save 25 %

In stock
SKU
HC03305-GL-TA_24510

$950.00

$712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent advances in phage therapeutics, skin microbiome, COVID-19 diagnostics and vaccines, and 3D bioprinting. It also evaluates developments across genomic, transcriptomic, and cell-based technological advances for precision medicine applications.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Bacterial Infection, PhagoMed, Bacteriophage, Skin microbes, microbiome, DSM, COVID-19, diagnostic, therapy, Mologic, Machine Learning, Sepsis, Dascena, predictive biomarker, Genmark, DNA hybridization, eSensor, Mobidiag, mechanophenotyping, mRNA vaccine, CureVac, mRNA delivery, Arcturus, Geneilabs, bioelectric drugs, Tufts University, Helium Ion therapy, RaySearch labs, Teplizumab, Provention Bio, gene therapy, Trinity College, RNAi, Evox, cell culture, eppendorf, Ona Therapeutics, antibodies, liver cancer, NCI, Cerevasc, hydrocephalus, 2.5D, Tokyo University, Cue Health, University of California, gene editing, Minnesota University, 3D printing, Scripps, Illumina, NGS, Orca Bio, Cell Therapy

Table of Contents

Technology Advances in Life Sciences, Health & Wellness

  • Bacterial Infection Treatment Through Phage-based Therapeutics
  • Bacteriophage and Endolysins for Treatment of AMR
  • Skin Microbes: A Key to Enhance Skin Health and Appearance
  • Microbial Innovations for Skin Health
  • Point-of-Care COVID-19 Diagnostic Test
  • Transforming Rapid Diagnosis for Human Diseases and Agriculture
  • Machine Learning-based Algorithm for Sepsis Diagnosis
  • Digital Predictive Biomarker for Sepsis
  • Competitive DNA Hybridization and Electrochemical Technology for COVID-19 Diagnosis
  • eSensor Technology for Molecular Diagnosis
  • Finnish CE-IVD Diagnostic Test for COVID-19 and Beyond
  • Reliable Diagnosis for Small Laboratories
  • Sepsis Diagnosis Through Cell Mechanical Properties
  • Mechanophenotyping: Next Generation of Diagnosis
  • German mRNA-based Vaccine for COVID-19
  • mRNA Vaccines: A Potential Therapeutics for a Range of Diseases
  • Lipid-enabled mRNA Delivery System
  • Lipid-enabled mRNA Delivery System for COVID-19
  • Cost-effective COVID-19 Testing Kits
  • Academic Collaborations to Develop Diagnostic Kits
  • Technology Attributes
  • Nicotine-related Brain Damage is Repairable
  • Technology Attributes
  • Expanding the Capabilities of Radiotherapy
  • Technology Attributes
  • Increasing Life Expectancy with the Help of Monoclonal Antibodies
  • Gene Therapy for Retinitis Pigmentosa
  • Organoid Model for Preliminary Study
  • Technology Attributes
  • Big Pharma Exploring Exosome Therapeutics
  • Fiber-based Disks to Increase Cell Culture Yield
  • Simple Polymer Material Suitable for Various Cell Lines
  • Antibodies to Treat Metastatic Cancer
  • Ona Therapeutics Carries Out Pre-clinical Trials
  • Liver Cancer Detection by Viral Exposure Signature
  • Growth Opportunities
  • First-in-human Testing of Minimally Invasive Procedure for Treating Hydrocephalus
  • Growth Opportunities
  • 2.5D Organoid Culture as Model for Bladder Cancer Studies
  • Growth Opportunities
  • Growing Need for COVID-19 Portable Testing Kits
  • Opportunities Across Industries/ Applications
  • Gene Edited Immune Cells Grow into Potent Tumor Killers
  • Growth Opportunities
  • 3D Printing of Compliant Biomedical Sensors Directly on Organs
  • Growth Opportunities
  • Prospective Neutralizing Antibodies Against COVID-19
  • Growth Opportunities
  • Next-gen Sequencing Test for COVID-19
  • Growth Opportunities
  • High-precision Cell Therapy for Blood Cancer
  • Growth Opportunities

Industry Interactions

  • Key Contacts
  • Key Contacts
  • Key Contacts
  • Key Contacts
  • Key Contacts
  • Key Contacts
  • Your F&S Thought Leader
Related Research
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent advances in phage therapeutics, skin microbiome, COVID-19 diagnostics and vaccines, and 3D bioprinting. It also evaluates developments across genomic, transcriptomic, and cell-based technological advances for precision medicine applications. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Bacterial Infection, PhagoMed, Bacteriophage, Skin microbes, microbiome, DSM, COVID-19, diagnostic, therapy, Mologic, Machine Learning, Sepsis, Dascena, predictive biomarker, Genmark, DNA hybridization, eSensor, Mobidiag, mechanophenotyping, mRNA vaccine, CureVac, mRNA delivery, Arcturus, Geneilabs, bioelectric drugs, Tufts University, Helium Ion therapy, RaySearch labs, Teplizumab, Provention Bio, gene therapy, Trinity College, RNAi, Evox, cell culture, eppendorf, Ona Therapeutics, antibodies, liver cancer, NCI, Cerevasc, hydrocephalus, 2.5D, Tokyo University, Cue Health, University of California, gene editing, Minnesota University, 3D printing, Scripps, Illumina, NGS, Orca Bio, Cell Therapy
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-15-00-00
Is Prebook No
Ti Codes D759